Fetuin-A, also termed alpha2-Heremans-Schmid glycoprotein, is a 46 kDa hepatocyte
derived protein (hepatokine) and serves multifaceted functions.(i) It acts as systemic inhibitor …

The prevalence of NAFLD (non-alcoholic fatty liver disease) is a rapidly increasing problem,
affecting a huge population around the globe. However, CVDs (cardiovascular diseases) …

Abstract Background Thoracic Aortic Aneurysms (TAAs) develop asymptomatically and are
characterized by dilatation of the aorta. This is considered a life-threatening vascular …

Peripheral arterial disease (PAD) is one of the most common manifestations of systemic
atherosclerosis. The prevalence of unrecognized PAD is high, leading to a lack of …

Background: In this study we sought to examine whether transcatheter aortic valve
implantation (TAVI) is followed by a change in the plasma levels of novel cardiovascular …

Background: Among patients with chronic heart failure (CHF), response shifts are common
in assessing treatment effects. However, few studies focused on potential response shifts in …

Present study was conducted to establish the interaction of bovine fetuin-A to validate its
binding modalities with doxorubicin (Dox). Fetuin-A was purified to highest purity and …

Adipokines, which have pleiotropic activities, are known to be involved in inflammation as
adipocytokines. The aim of the current study was to investigate selected adipocytokine …

Heart failure (HF) demonstrates an epidemic-shaped growth worldwide and continues to be
a staggering health problem regardless of unprecedented efforts in diagnosis and treatment …

Abstract Fetuin-A (α2Heremans-Schmid glycoprotein) is a glycoprotein which is synthesized
in the liver and secreted into the bloodstream. It belongs to a large group of binding proteins …